Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment - Jonathan I. Silverberg; Andreas Wollenberg; Linda Stein Gold; James Del Rosso; Gil Yosipovitch; Peter Lio; Jose-Manuel Carrascosa; Gaia Gallo; Yuxin Ding; Zhenhui Xu; Marta Casillas; Evangeline Pierce; et al. (Adis, Springer Healthcare, 2024)